SEARCH
Enter your search term below:
INSIGHTS / News
University spin-out “Azellon” announces recruitment phase of knee repair clinical trial
Azellon Ltd, (“Azellon”), a spin-out from the University of Bristol and the developer of stem cell therapies for tissue repair, today announced that recruitment had commenced for the phase I/IIa trial of its Cell Bandage for knee meniscus repair.
Built upon the pioneering work of Professor Anthony Hollander from the University’s School of Cellular and Molecular Medicine, the Azellon procedure takes stem cells, harvested from the patient’s own bone marrow, grows them on a structural bio-scaffold, and two weeks later implants the newly created Cell Bandage into the patient’s knee.
Read the full story on the University website
Mailing List sign-up
Get all the fresh insights first! Stay up-to-date with all the
latest investment news, blogs and all things SETsquared.
Close 
Mailing List sign-up
LATEST
TWEETS
Ever thought how do I make my business proposition attractive in the eyes of an investor? We spoke with 3 experts f… twitter.com/i/web/status/11630…
Want to know how our #ScaleUp Programme can support your growing business? Find out first hand from these SME found… twitter.com/i/web/status/11626…
Only two days left to apply for our #ICURe Programme - the deadline is 19 August. Find out more about the programme… twitter.com/i/web/status/11624…
Test your #SETsquared knowledge by checking out these #Top10Facts that everyone should know about us! Prepare to be… twitter.com/i/web/status/11623…
Did you know that we have an #onlineinvestment platform where investors can now view and invest in innovative Scale… twitter.com/i/web/status/11623…
